Acute refractory intestinal pseudo-obstruction in MELAS: Efficacy of prucalopride
暂无分享,去创建一个
[1] Mellar P. Davis,et al. New Options in Constipation Management , 2015, Current Oncology Reports.
[2] A. Ramesh,et al. The successful treatment of acute refractory pseudo‐obstruction with prucalopride , 2012, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.
[3] J. Camm,et al. Assessment of the cardiac safety of prucalopride in healthy volunteers: a randomized, double-blind, placebo- and positive-controlled thorough QT study , 2012, British journal of clinical pharmacology.
[4] J. Tack. Prucalopride: a new drug for the treatment of chronic constipation , 2009, Expert review of gastroenterology & hepatology.
[5] D. Turnbull,et al. GASTROINTESTINAL TRACT INVOLVEMENT ASSOCIATED WITH THE 3243A>G MITOCHONDRIAL DNA MUTATION , 2008, Neurology.
[6] Hsiu-Fen Lee,et al. Paralytic ileus in MELAS with phenotypic features of MNGIE. , 2004, Pediatric neurology.
[7] J. Lavine,et al. Gastrointestinal complications of mitochondrial disease. , 2004, Mitochondrion.
[8] D. Faigel,et al. Acute colonic pseudo-obstruction. , 2002, Gastrointestinal endoscopy.
[9] S. Dorudi,et al. Acute colonic pseudo‐obstruction , 1992, The British journal of surgery.